Skip to content
LexBuild

Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC

---
identifier: "/us/fr/2020-05748"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC"
title_number: 0
title_name: "Federal Register"
section_number: "2020-05748"
section_name: "Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC"
positive_law: false
currency: "2020-03-19"
last_updated: "2020-03-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2020-05748"
document_type: "notice"
publication_date: "2020-03-19"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "85 FR 15814"
fr_volume: 85
docket_ids:
  - "Docket No. DEA-591"
comments_close_date: "2020-05-18"
fr_action: "Notice of application."
---

#  Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC

**ACTION:**

Notice of application.

**DATES:**

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 18, 2020.

**ADDRESSES:**

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA *Federal Register* Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

**SUPPLEMENTARY INFORMATION:**

In accordance with 21 CFR 1301.33(a), this is notice that on November 6, 2019, Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070-3244 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

| Controlled | Drug | Schedule |
| --- | --- | --- |
| Gamma Hydroxybutyric Acid | 2010 | I |
| Dihydromorphine | 9145 | I |
| Hydromorphinol | 9301 | I |
| Methylphenidate | 1724 | II |
| Amobarbital | 2125 | II |
| Pentobarbital | 2270 | II |
| Secobarbital | 2315 | II |
| Codeine | 9050 | II |
| Oxycodone | 9143 | II |
| Hydromorphone | 9150 | II |
| Hydrocodone | 9193 | II |
| Methadone | 9250 | II |
| Methadone intermediate | 9254 | II |
| Morphine | 9300 | II |
| Oripavine | 9330 | II |
| Thebaine | 9333 | II |
| Opium tincture | 9630 | II |
| Oxymorphone | 9652 | II |

The company plans to manufacture the listed controlled substances in bulk for sale to its customers.

Dated: February 10, 2020.

William T. McDermott,

Assistant Administrator.